Joseph Miller

Joseph Miller

Director of Finance/CFO presso AURINIA PHARMACEUTICALS INC.

Patrimonio netto: 2 M $ in data 31/03/2024

50 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Joseph M.
Miller
is currently the Chief Financial Officer at Aurinia Pharmaceuticals, Inc. He previously worked as the Senior Director-Accounting at Qiagen Genomics, Inc. from 2006 to 2015.
From 2018 to 2022, he served as the Director at Avalo Therapeutics, Inc. Prior to that, he was the Vice President-Finance at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Mr. Miller also held the position of Chief Financial Officer & Vice President-Finance at Eppendorf-5 Prime, Inc. from 2002 to 2006.
He obtained his undergraduate degree from Villanova University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
06/03/2024 495 928 ( 0.34% ) 2 M $ 31/03/2024

Posizioni attive di Joseph Miller

SocietàPosizioneInizio
AURINIA PHARMACEUTICALS INC. Director of Finance/CFO 27/04/2020
Tutte le posizioni attive di Joseph Miller

Precedenti posizioni note di Joseph Miller

SocietàPosizioneFine
AVALO THERAPEUTICS, INC. Director of Finance/CFO 24/04/2020
SUCAMPO PHARMACEUTICALS, INC. Director of Finance/CFO 01/04/2018
Comptroller/Controller/Auditor 01/01/2015
Eppendorf-5 Prime, Inc. Director of Finance/CFO 01/01/2006
Vedi nel dettaglio l'esperienza di Joseph Miller

Formazione di Joseph Miller

Villanova University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Joseph Miller

Relazioni

74

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
AVALO THERAPEUTICS, INC.

Health Technology

AURINIA PHARMACEUTICALS INC.

Health Technology

Aziende private3

Commercial Services

Health Technology

Eppendorf-5 Prime, Inc.

Vedi le connessioni aziendali